期刊
RHEUMATOLOGY
卷 56, 期 -, 页码 V27-V32出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex203
关键词
scleroderma; lung disease; interstitial lung disease clinical trials
类别
资金
- EULAR
Interstitial lung disease causes major morbidity and mortality in patients with systemic sclerosis (SSc-ILD). Large randomized clinical trials in SSc-ILD have provided important information regarding the feasibility, reliability and validity of outcome measures. Forced vital capacity percentage predicted should be considered as a primary outcome measure, with inclusion of appropriate radiological and patient-reported measures. We provide practical recommendations for trial design in SSc-ILD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据